Noble Corporation plc vs Novavax Inc — how do they compare? Noble Corporation plc trades at $44.25 (market cap $7.10B), while Novavax Inc trades at $7.92 (market cap $1.31B). The key difference: Noble Corporation plc is far larger — about 5.4× Novavax Inc's market cap, and Noble Corporation plc pays a 4.5% dividend while Novavax Inc pays none. Which is the better fit depends on your goals.
| NE | NVAX | |
|---|---|---|
Market Cap | $7.10B | $1.31B |
Sector | Technology | Health |
52-Week High | $54.37 | $11.19 |
52-Week Low | $26.61 | $6.22 |
Enterprise Value | $8.53B | $889.30M |
Dividend Yield | 4.5% | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Novavax (NVAX) trades at $7.89, down 0.75% on the day, with a bullish technical signal despite mixed indicators. The company reported a strong Q2 2026 earnings beat, raising its full-year revenue outlook, while maintaining a low valuation with a P/E of 3.14 and EV/EBITDA of 1.72. However, negative net income margin and shareholder equity highlight financial challenges.
The outlook is cautiously optimistic, driven by partnership milestones with Sanofi and cost reductions, but risks include persistent cash burn and competitive vaccine market pressures. Analyst consensus leans bullish with 74% buy ratings, suggesting potential upside if execution improves.
Trailing returns across standard periods
Noble Corporation plc is a leading offshore drilling contractor for the oil and gas industry. The company owns and operates a high-specification fleet of mobile offshore drilling units, including drillships and semi-submersibles, that are used for exploration and production activities in deepwater and harsh environments worldwide. Noble focuses on providing safe, efficient, and reliable drilling services to major and independent oil and gas companies globally.
Read more on NE →Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →